Without continued and increased national and international efforts, rising HIV drug resistance could jeopardize a decade-long trend of decreasing HIV/Aids-related illness and death in low- and middle-income countries.
The benefit that the Africans got from a mutation that gave them some resistance to malaria has, statistically at least, rendered them some increased susceptibility to HIV.